أرسل هذا في رسالة قصيرة: Tumor marker analyses from the phase III, placebo-controlled, FASTACT-2 study of intercalated erlotinib with gemcitabine/platinum in the first-line treatment of advanced non-small-cell lung cancer

 _    _     ______   __   __     ___     _    _   
| || | ||  /_   _//  \ \\/ //   / _ \\  | |  | || 
| || | ||   -| ||-    \   //   / //\ \\ | |/\| || 
| \\_/ ||   _| ||_    / . \\  |  ___  |||  /\  || 
 \____//   /_____//  /_//\_\\ |_||  |_|||_// \_|| 
  `---`    `-----`   `-`  --` `-`   `-` `-`   `-`